My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
27 JUL 2012 Study suggests prostate cancer management should emphasize healthy lifestyle changes Boston, MA – Men diagnosed with prostate cancer are less likely to die from the disease than…
Contact: Kay Roche kay@rochewriting.com ECCO-the European CanCer Organisation Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it…
Contact: Kay Roche kay@rochewriting.com ECCO-the European CanCer Organisation Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it…
2009 study posted for filing Contact: David Sampson david.sampson@cancer.org American Cancer Society ATLANTA—June 29, 2009—The recent release of two large randomized trials suggests that if there is a benefit of…
Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care,…
Public release date: 20-Feb-2009 New York, NY, February 20, 2009 – Although widespread Prostate-Specific-Antigen (PSA) testing has undoubtedly decreased prostate cancer mortality, is there a point of diminishing returns?…
You must be logged in to post a comment.